:: Arrien Pharmaceuticals, LLC. ::

Arrien Pharmaceuticals is a small molecule targeted therapeutics drug discovery and development company working towards targeting cell signaling pathways - A target class in treating neurodegenerative, Cancer, Inflammatory and Metabolic diseases. The Arrien is applying its proprietary platform to successfully discover a portfolio of uniquely identified pre-clinical stage programs in Parkinson's, Alzheimer's Diseases (PD, AD), Cancer, Rheumatoid Arthritis (RA), Diabesity diseases. Read More..

Arrien pharmaceutical company's potential pipeline, objectives and success are reflected from expertise in Medicinal Chemistry and Pharmaceutical experience enabled to execute its product pipeline in a short period of time.

Arrien is committed to the proper identification, quality, purity, and strength of the pre-clinical or investigational drug and to assure that it is reasonably safe to conduct the proposed clinical investigations.